Ruth de Tute

3PUBLICATIONS

11CO-AUTHORS

Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 20, 2024

PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia.

Jaimal Kothari, Toby Eyre, Ali Rismani

|Oct 12, 2021

Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.

Wei Yee Chan, Nicholas Counsell, Ruth de Tute

|Mar 14, 2021

Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.

Rakesh Popat, Nicholas Counsell, Ruth de Tute

Pageof 1

Frequent Collaborators

2 joint publications

Dunnya De-Silva

2 joint publications

Elizabeth H Phillips

2 joint publications

Treen C Morris

2 joint publications

Gordon Cook

2 joint publications

Kwee Yong

1 joint publications

Rakesh Popat

1 joint publications

Wei Yee Chan

1 joint publications

Jaimal Kothari

1 joint publications

Toby Eyre

1 joint publications

Kushani Ediriwickrema

Frequent Collaborators

2 joint publications

Dunnya De-Silva

2 joint publications

Elizabeth H Phillips

2 joint publications

Treen C Morris

2 joint publications

Gordon Cook